Anti-fibrotic effects of nintedanib on lung fibroblasts derived from patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs).
Joannes A, Voisin T, Morzadec C, Letellier A, Gutierrez FL, Chiforeanu DC, Le Naoures C, Guillot S, De Latour BR, Rouze S, Jaillet M, Crestani B, Wollin L, Jouneau S, Vernhet L.
Joannes A, et al. Among authors: rouze s.
Pulm Pharmacol Ther. 2023 Dec;83:102267. doi: 10.1016/j.pupt.2023.102267. Epub 2023 Nov 15.
Pulm Pharmacol Ther. 2023.
PMID: 37972706
Free article.